Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Synthes Holding AG

More Headlines »« Less Headlines

Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States.

Read More at Wikipedia ›

Related Topics

  1. Johnson Controls
  2. Swiss Exchange
  3. Kevin Johnson
  4. William R. Johnson
  5. Bill Weldon
  6. Mead Johnson & Company
Get updates on Synthes Holding AG
J&J New CEO: Top Job Is Fixing Over-The-Counter Drug Business

NEW BRUNSWICK, N.

J. -(Dow Jones)- Alex Gorsky, Johnson & Johnson's (JNJ) incoming chief executive, said his No. 1 priority was fixing the problems in the company's over-the-counter medicine business, which has been hurt by recalls that have dimmed sales and damaged the health-care giant's reputation.Mr. Gorsky, who takes the helm of J&J from William Weldon on Thursday, voiced confidence that the health-care giant has taken the steps needed to revive the business and reintroduce withdrawn products while upgrading manufacturing."No. 1, we've got to get product on the shelves, and I'm very confident our teams can rebuild a lot of these brands," Mr. Gorsky said in an interview Wednesday.Starting in late 2009, J&J began recalling iconic medicines like children's Tylenol after finding metal shavings were found in some bottles, as well as excessive concentrations of active ingredients and bad odors. Earlier this year, the company was forced to recall some Tylenol that it had put back on store...

Read More ›

  1. New J&J CEO Lauded As Smart, Tested; Unlikely To Alter Strategy

    Johnson & Johnson's (JNJ) incoming CEO is viewed as having the experience and skills to lead the company out of a difficult period, but he's unlikely to change J&J's...

  2. Synthes 2011 Net Earnings Rise 6.5% Ahead Of J&J Merger

    Synthes Inc. (SYST.VX) Thursday reported a 6.5% increase in full-year earnings ahead of its planned merger with Johnson & Johnson (JNJ) later this year.MAIN FACTS:- ...

  3. Nobel Biocare Rebound Hopes Dashed On Weak Results, Outlook

    Hopes the advent of former Nestle SA (NESN.VX) manager Richard Laube as Chief Executive of Nobel Biocare Holding AG would translate into a quick rebound of the denta...

  4. Johnson & Johnson 4Q Profit Slumps 89% On Charges

    Johnson & Johnson (JNJ) reported an 89% drop in fourth-quarter profit due to legal settlements and product-liability costs, while the health-care giant avoided a thi...

  5. Fed Statement, Conference Boost Stocks

    FOX Business: The Power to ProsperThe markets rallied for a second-straight day after the Federal Reserve said it plans on keeping short-term interest rates at extra...

  6. Fed Statement, Conference Boost Stocks

    FOX Business: The Power to ProsperThe markets rallied for a second-straight day after the Federal Reserve said it plans on keeping short-term interest rates at extra...

  7. J&J to Buy Synthes for $21.6 Billion

    Johnson & Johnson (NYSE:JNJ) snatched up Swiss medical devices maker Synthes on Wednesday in a cash-and-stock deal worth $21.3 billion.The transaction marks New Brun...

  8. J&J to buy Synthes for $21.5 billion: report

    Bangalore (Reuters) - U.S. healthcare conglomerate Johnson & Johnson is expected to announce a $21.5 billion deal to buy Swiss medical device maker Synthes Inc on We...

  9. Shy Synthes chairman could fly group to J&J

    By Katie ReidZURICH (Reuters) - Flying fanatic Hansjoerg Wyss, chairman of Swiss medical device maker Synthes <SYST.VX>, has navigated his group into the flight path...

  10. European Markets Slide Amid Euro Debt Fears

    European shares dropped to a three-week low in morning trade on Monday on nervousness ahead of quarterly earnings results and lingering worries about indebted euro z...

  11. Synthes Confirms Talks With Johnson & Johnson

    LONDON -- Synthes Inc. confirmed on Monday it's in talks with Johnson & Johnson about a potential business combination. "No assurance can be given as to whether, whe...

  12. Synthes confirms in deal talks with J&J

    By Katie ReidZURICH (Reuters) - Synthes <SYST.VX> said on Monday it was in takeover talks with Johnson & Johnson <JNJ.N>, after reports the U.S. group is looking to ...

  1. EU Approves Synthes Buy By Johnson & Johnson

    The European Commission cleared Thursday the acquisition of Synthes Inc. (SYST.VX), an orthopaedic medical devices company, by Johnson & Johnson (JNJ).The competitio...

  2. J&J 1Q Profit Up 12.5% On Forex Gain, Sales Down Slightly

    Johnson & Johnson (JNJ) Tuesday reported a slight decline in first-quarter sales because of drug patent expirations and manufacturing constraints, but the company po...

  3. Johnson & Johnson 1Q Profit Up On Forex Gain,Lower Costs

    ("Johnson & Johnson 1Q Profit Rose 12% On Forex Gain, Lower Costs," published at 8:36 a.m. EDT, misstated the change in revenue in the fifth paragraph. A corrected v...

  4. Biomet Offers To Buy DePuy Trauma Business For $280 Million

    DOW JONES NEWSWIRESBiomet Inc. has made a binding offer to acquire the global trauma business of Johnson & Johnson's (JNJ) DePuy Orthopaedics Inc. for about $280 mil...

  5. Synthes , Kuros Sign License And Development Agreement

    Synthes Inc. (SYST.VX) Tuesday said it and Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial co...

  6. Johnson & Johnson Set To Receive EU Approval Of $21.3 Billion Synthes Deal -Reuters

    DOW JONES NEWSWIRESJohnson & Johnson (JNJ) is set to receive European Union approval for its $21.3 billion purchase of Swiss medical device company Synthes Inc. (SYS...

  7. Synthes Received FDA Warning Letter On Complaint Procedures

    Synthes Inc. (SYST.VX) received a warning letter from federal regulators last month regarding complaint procedures at its facility in West Chester, Pa.The letter, is...

‹ Prev12Next ›
Freebase CC-BY
Source: Synthes Holding AG on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL